跳至主要内容
临床试验/NCT04953039
NCT04953039已完成不适用

Use of Saliva for Diagnosis of SARS-CoV2 Infection

University of Milano Bicocca1 个研究点 分布在 1 个国家目标入组 109 人开始时间: 2020年11月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
109
试验地点
1
主要终点
Presence of SARS-CoV2 RNA in the saliva of patient with suspected or confirmed COVID-19.

研究概览

简要总结

Aim of the study is to evaluate the presence of SARS-CoV2 RNA in the saliva of patients with suspected or confirmed COVID-19 in order to validate the analysis of this type of sample for the diagnosis of SARS-CoV2 infections.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients ≥ 18 years of age hospitalized in the COVID-19 wards of ASST Monza - San Gerardo Hospital with positive, weakly positive or negative nasopharyngeal swabs; initially assessed at the E.R.; symptomatic or asymptomatic with indication to hospitalization.
  • Informed consent freely granted and acquired before the start of the study.

排除标准

  • Patients with significant clinical conditions which could interfere with the study in the opinion of the researchers.

结局指标

主要结局

Presence of SARS-CoV2 RNA in the saliva of patient with suspected or confirmed COVID-19.

时间窗: Up to 52 weeks

Positive - Negative

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Giorgio Novelli

Principal Investigator

University of Milano Bicocca

研究点 (1)

Loading locations...

相似试验